Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety of an Infant Formula Containing Bifidobacterium Breve PS1, a Strain Isolated From Human Milk, in a Pilot Trial.

NCT05973812 is registered in ClinicalTrials.gov with Universidad Complutense de Madrid as lead sponsor.

NCT NCT05973812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05973812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety of an Infant Formula Containing Bifidobacterium Breve PS1, a Strain Isolated From Human Milk, in a Pilot Trial.
Lead sponsor
Universidad Complutense de Madrid
Phase
Not applicable
Overall status
Completed
Start date
December 12, 2012
Completion date
March 12, 2015
Enrollment
80 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

infant development, safety issues